These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 27338042)
21. Upregulation of p300 in paclitaxel-resistant TNBC: implications for cell proliferation via the PCK1/AMPK axis. Zhao PW; Cui JX; Wang XM Pharmacogenomics J; 2024 Feb; 24(2):5. PubMed ID: 38378770 [TBL] [Abstract][Full Text] [Related]
22. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells. Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401 [TBL] [Abstract][Full Text] [Related]
23. MiR-153-5p Enhances the Sensitivity of Triple-Negative Breast Cancer Cells to Paclitaxel by Inducing G2M Phase Arrest. Wang Y; Wu N; Zhang J; Wang H; Men X Onco Targets Ther; 2020; 13():4089-4097. PubMed ID: 32494162 [TBL] [Abstract][Full Text] [Related]
24. MicroRNA-126 alleviates endothelial cells injury in atherosclerosis by restoring autophagic flux via inhibiting of PI3K/Akt/mTOR pathway. Tang F; Yang TL Biochem Biophys Res Commun; 2018 Jan; 495(1):1482-1489. PubMed ID: 29203244 [TBL] [Abstract][Full Text] [Related]
25. Licochalcone A restrains microphthalmia-associated transcription factor expression and growth by activating autophagy in melanoma cells via miR-142-3p/Rheb/mTOR pathway. Zhang Y; Gao M; Chen L; Zhou L; Bian S; Lv Y Phytother Res; 2020 Feb; 34(2):349-358. PubMed ID: 31793097 [TBL] [Abstract][Full Text] [Related]
26. miR-142-3p improves paclitaxel sensitivity in resistant breast cancer by inhibiting autophagy through the GNB2-AKT-mTOR Pathway. Shi Y; Wang J; Tao S; Zhang S; Mao L; Shi X; Wang W; Cheng C; Shi Y; Yang Q Cell Signal; 2023 Mar; 103():110566. PubMed ID: 36539001 [TBL] [Abstract][Full Text] [Related]
27. GBP2 enhances paclitaxel sensitivity in triple‑negative breast cancer by promoting autophagy in combination with ATG2 and inhibiting the PI3K/AKT/mTOR pathway. Zhang W; Tang X; Peng Y; Xu Y; Liu L; Liu S Int J Oncol; 2024 Apr; 64(4):. PubMed ID: 38334171 [TBL] [Abstract][Full Text] [Related]
28. MicroRNA-101 inhibits cell progression and increases paclitaxel sensitivity by suppressing MCL-1 expression in human triple-negative breast cancer. Liu X; Tang H; Chen J; Song C; Yang L; Liu P; Wang N; Xie X; Lin X; Xie X Oncotarget; 2015 Aug; 6(24):20070-83. PubMed ID: 26036638 [TBL] [Abstract][Full Text] [Related]
29. Effects of endoplasmic reticulum stress on the autophagy, apoptosis, and chemotherapy resistance of human breast cancer cells by regulating the PI3K/AKT/mTOR signaling pathway. Zhong JT; Yu J; Wang HJ; Shi Y; Zhao TS; He BX; Qiao B; Feng ZW Tumour Biol; 2017 May; 39(5):1010428317697562. PubMed ID: 28459209 [TBL] [Abstract][Full Text] [Related]
30. miR-200c/PAI-2 promotes the progression of triple negative breast cancer via M1/M2 polarization induction of macrophage. Meng Z; Zhang R; Wang Y; Zhu G; Jin T; Li C; Zhang S Int Immunopharmacol; 2020 Apr; 81():106028. PubMed ID: 31801690 [TBL] [Abstract][Full Text] [Related]
31. Resveratrol transcriptionally regulates miRNA-18a-5p expression ameliorating diabetic nephropathy via increasing autophagy. Xu XH; Ding DF; Yong HJ; Dong CL; You N; Ye XL; Pan ML; Ma JH; You Q; Lu YB Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4952-4965. PubMed ID: 29164562 [TBL] [Abstract][Full Text] [Related]
32. Estradiol inhibits osteoblast apoptosis via promotion of autophagy through the ER-ERK-mTOR pathway. Yang YH; Chen K; Li B; Chen JW; Zheng XF; Wang YR; Jiang SD; Jiang LS Apoptosis; 2013 Nov; 18(11):1363-1375. PubMed ID: 23743762 [TBL] [Abstract][Full Text] [Related]
33. Eriocalyxin B, a novel autophagy inducer, exerts anti-tumor activity through the suppression of Akt/mTOR/p70S6K signaling pathway in breast cancer. Zhou X; Yue GG; Chan AM; Tsui SK; Fung KP; Sun H; Pu J; Lau CB Biochem Pharmacol; 2017 Oct; 142():58-70. PubMed ID: 28669564 [TBL] [Abstract][Full Text] [Related]
34. Homoharringtonine inhibited breast cancer cells growth via miR-18a-3p/AKT/mTOR signaling pathway. Wang LB; Wang DN; Wu LG; Cao J; Tian JH; Liu R; Ma R; Yu JJ; Wang J; Huang Q; Xiong WY; Zhang X Int J Biol Sci; 2021; 17(4):995-1009. PubMed ID: 33867824 [TBL] [Abstract][Full Text] [Related]
35. Autophagy inhibition enhances RAD001-induced cytotoxicity in human bladder cancer cells. Lin JF; Lin YC; Yang SC; Tsai TF; Chen HE; Chou KY; Hwang TI Drug Des Devel Ther; 2016; 10():1501-13. PubMed ID: 27143856 [TBL] [Abstract][Full Text] [Related]
36. MicroRNA 100 sensitizes luminal A breast cancer cells to paclitaxel treatment in part by targeting mTOR. Zhang B; Zhao R; He Y; Fu X; Fu L; Zhu Z; Fu L; Dong JT Oncotarget; 2016 Feb; 7(5):5702-14. PubMed ID: 26744318 [TBL] [Abstract][Full Text] [Related]
37. Eribulin upregulates miR-195 expression and downregulates Wnt3a expression in non-basal-like type of triple-negative breast cancer cell MDA-MB-231. Furuya K; Sasaki A; Tsunoda Y; Tsuji M; Udaka Y; Oyamada H; Tsuchiya H; Oguchi K Hum Cell; 2016 Apr; 29(2):76-82. PubMed ID: 26573286 [TBL] [Abstract][Full Text] [Related]
38. Tetrandrine-Induced Autophagy in MDA-MB-231 Triple-Negative Breast Cancer Cell through the Inhibition of PI3K/AKT/mTOR Signaling. Guo Y; Pei X Evid Based Complement Alternat Med; 2019; 2019():7517431. PubMed ID: 30713576 [TBL] [Abstract][Full Text] [Related]
39. Hydroxytyrosol and Oleuropein Inhibit Migration and Invasion of MDA-MB-231 Triple-Negative Breast Cancer Cell via Induction of Autophagy. Lu HY; Zhu JS; Zhang Z; Shen WJ; Jiang S; Long YF; Wu B; Ding T; Huan F; Wang SL Anticancer Agents Med Chem; 2019; 19(16):1983-1990. PubMed ID: 31333142 [TBL] [Abstract][Full Text] [Related]
40. Silencing of MicroRNA-21 confers the sensitivity to tamoxifen and fulvestrant by enhancing autophagic cell death through inhibition of the PI3K-AKT-mTOR pathway in breast cancer cells. Yu X; Li R; Shi W; Jiang T; Wang Y; Li C; Qu X Biomed Pharmacother; 2016 Feb; 77():37-44. PubMed ID: 26796263 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]